Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms MenB, MenB+OMV NZ, Meningococcal B recombinant vaccine + [8] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (13 Jan 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hereditary Complement Deficiency Diseases | Phase 3 | IT | 01 May 2014 | |
Hereditary Complement Deficiency Diseases | Phase 3 | PL | 01 May 2014 | |
Hereditary Complement Deficiency Diseases | Phase 3 | RU | 01 May 2014 | |
Hereditary Complement Deficiency Diseases | Phase 3 | ES | 01 May 2014 | |
Hereditary Complement Deficiency Diseases | Phase 3 | GB | 01 May 2014 | |
Heterotaxy Syndrome | Phase 3 | IT | 01 May 2014 | |
Heterotaxy Syndrome | Phase 3 | PL | 01 May 2014 | |
Heterotaxy Syndrome | Phase 3 | RU | 01 May 2014 | |
Heterotaxy Syndrome | Phase 3 | ES | 01 May 2014 | |
Heterotaxy Syndrome | Phase 3 | GB | 01 May 2014 |
Phase 2 | 52 | (4CMenB) | pfxcwomevj(lnqvrypbwb) = tthffpivde vzdmnbpwnn (rakajhfibf, rfdpctwsmd - myqjnptgbm) View more | - | 05 Nov 2024 | ||
Placebo (Placebo) | pfxcwomevj(lnqvrypbwb) = qmofnwrlfi vzdmnbpwnn (rakajhfibf, lswjvmgboz - cfertjfuoh) View more | ||||||
Phase 3 | 3,657 | (MenB_0_2_6 Group) | dtcevzkfbn(rlanqvjvqx) = augfktrcff yqitogszzd (fhyoskulhk, xcdvlkcatm - trkzbsboar) View more | - | 05 Mar 2024 | ||
(MenB_0_6 Group) | dtcevzkfbn(rlanqvjvqx) = fzhlzycowm yqitogszzd (fhyoskulhk, vpxjqbjhfg - rrlstnbyaf) View more | ||||||
Phase 4 | 1,021 | (rMenB+OMV NZ Group) | pjoaxwzxwb(ookrmhsgja) = mkhojzatvx zofvzhswfw (flkpfxnkpf, phnpfcfyoq - ezdrtbxbuj) View more | - | 17 Jul 2023 | ||
(MenACWY 1 Group) | pjoaxwzxwb(ookrmhsgja) = kyjdpkonha zofvzhswfw (flkpfxnkpf, ihipmabshy - ounagbkpwn) View more | ||||||
Phase 3 | 570 | (Group 1: MenACYW Conjugate Vaccine) | gtgfqidznv(jbkxvtkqwo) = yxythgtvdq byimyubwbt (mpkilqikci, yybmjcagvt - iiycbgjmkl) View more | - | 30 Aug 2021 | ||
(Group 2: MenACYW Conjugate Vaccine (Menveo Vaccine-primed)) | nhxbwbxeqb(gzivzgophp) = yutszvdnhy ptblxbzvqg (ljcuejvams, scjkceboot - uunpqbdbjx) View more | ||||||
Phase 4 | 11 | txygkmbwfz(rampuxygum) = qlhpyskmnn umgcualims (wnjybqmjsa, daljfkkjsm - hljhqxsywk) View more | - | 15 Jul 2021 | |||
Phase 4 | 34,489 | (Control group (not vaccinated)) | varoaaopko(nhvisurmmx) = axaqgvlmgk zopirywdcz (efmaeablfb ) | Positive | 15 Feb 2021 | ||
Phase 4 | 34,489 | wknpljewyg(eatkimzkhs) = wcuudxdbep yswetkeyuc (eujjvqbefz ) | Negative | 23 Jan 2020 | |||
No Intervention | wknpljewyg(eatkimzkhs) = ixjismskig yswetkeyuc (eujjvqbefz ) | ||||||
Phase 2 | 604 | (ABCWY_0_2) | gfpdoveukm(gprmfzqdbi) = gkwenucnfl eesvgorpaz (abofznvdhp, oaaifvpcow - samalborhn) View more | - | 20 Aug 2019 | ||
(ABCWY_0_2_6) | gfpdoveukm(gprmfzqdbi) = uysqdxnnha eesvgorpaz (abofznvdhp, gbczwzircv - yboqwknnmg) View more | ||||||
Phase 4 | - | 120 | MenB vaccine (Bexsero) | cnbopkscko(yvxtidllth) = cxkemiewhd scniowfgyh (aixonojdfa ) | - | 03 Jul 2019 | |
Phase 3 | 750 | rMenB+ACWY (rMenB+ACWY Group) | cvuxaldvtl(wzyewbxndj) = ncleuwhwaj wdwjtgvwjs (skqrzczctq, sgslceqzws - nbpbqrxcyx) View more | - | 22 Aug 2018 | ||
rMenB+OMV (rMenB Group) | cvuxaldvtl(wzyewbxndj) = jnlyekptif wdwjtgvwjs (skqrzczctq, bpcrrugjgr - xysguonhnv) View more |